Catherine Thiéblemont
Inserm(FR)Université Paris Cité(FR)Saint Louis University Hospital(US)Université Sorbonne Paris Nord(FR)Sorbonne Paris Cité(FR)Assistance Publique – Hôpitaux de Paris(FR)Assistance Publique – Hôpitaux de Paris(FR)Centre Hospitalier Régional et Universitaire de Nancy(FR)Centre d’Investigation Clinique Innovation Technologique de Nancy(FR)Délégation Centre-Est(FR)Hôpital Saint-Louis(FR)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, Chronic Lymphocytic Leukemia Research, CAR-T cell therapy research, Viral-associated cancers and disorders, CNS Lymphoma Diagnosis and Treatment
Most-Cited Works
- → Long-term outcome of patients in the LNH-98.5 trial, the first randomized study comparing rituximab-CHOP to standard CHOP chemotherapy in DLBCL patients: a study by the Groupe d'Etudes des Lymphomes de l'Adulte(2010)1,528 cited
- → Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome(2007)900 cited
- → Randomized Phase III Trial of Ibrutinib and Rituximab Plus Cyclophosphamide, Doxorubicin, Vincristine, and Prednisone in Non–Germinal Center B-Cell Diffuse Large B-Cell Lymphoma(2019)600 cited
- → Attenuated immunochemotherapy regimen (R-miniCHOP) in elderly patients older than 80 years with diffuse large B-cell lymphoma: a multicentre, single-arm, phase 2 trial(2011)533 cited
- → Mucosa-associated lymphoid tissue lymphoma is a disseminated disease in one third of 158 patients analyzed(2000)517 cited